FDA Approvals - Boca Pharmacal Receives FDA Approval For Generic Version Of Panlor SS;
Boca Pharmacal Receives FDA Approval For Generic Version Of Panlor SS; Signs Exclusive Marketing And Distribution ... (PharmaceuticalOnline)
Boca Pharmacal, Inc. made two major announcements with the U.S. Food and Drug Administration granting its final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Panlor SS (Acetaminophen, Caffeine and Dihydrocodeine) and the signing of an exclusive marketing and distribution agreement with Tedor Pharma Inc. for Didrex (Benzphetamine ...
ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine (RedNova)
ArthroCare (Nasdaq:ARTC), a multi-business medical device company that develops minimally invasive surgical products, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its Cavity SpineWand to reduce malignant lesions within the vertebrae.